ページ本文へ移動
pepts.wiki

私たちは医師ではなく、ここにある内容は医療上の助言ではありません。必ず先に医療専門家に相談してください。 この表示をする理由

英語からの機械翻訳です。英語版が基準です。 英語で読む

栄養素または補酵素Stub

NADH

補酵素NADの還元型

補酵素NADの還元型です。サプライヤーが単体およびブレンド製品として販売しているため、このライブラリに掲載されていますが、研究用ペプチドではありません。

概要

栄養素または補酵素

ビタミン、アミノ酸、または補酵素です。単独および配合製品として販売されているため掲載しています。

このページは作成途中です

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

NADH: PubMedで

What PubMed held for NADH on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

65
papers
32
in humans
6
clinical trials
5
randomized trials
2012: 3 papers122013: 3 papers2014: 2 papers142015: 3 papers2016: 1 papers162017: 3 papers2018: 1 papers182019: 2 papers2020: 2 papers202021: 1 papers2022: 3 papers222023: 3 papers2024: 2 papers242025: 6 papers2026: 5 papers so far26
Papers per year, 2012 to 2026. The most in one year: 6.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

    Randomized trialCastro-Marrero J, Segundo MJ, Lacasa M, et al. Nutrients, 2021. PMID 34444817

  2. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome

    Randomized trialSantaella ML, Font I, Disdier OM Puerto Rico health sciences journal, 2004. PMID 15377055

  3. [Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome]

    Randomized trialAlegre J, Rosés JM, Javierre C, et al. Revista clinica espanola, 2010. PMID 20447621

  4. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome

    Randomized trialForsyth LM, Preuss HG, MacDowell AL, et al. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999. PMID 10071523

  5. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?

    Randomized trialCastro-Marrero J, Cordero MD, Segundo MJ, et al. Antioxidants & redox signaling, 2015. PMID 25386668

  6. No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia

    TrialRainer M, Kraxberger E, Haushofer M, et al. Journal of neural transmission (Vienna, Austria : 1996), 2000. PMID 11459000

  7. In Vivo NADH/NAD(+) Biosensing Reveals the Dynamics of Cytosolic Redox Metabolism in Plants

    StudySteinbeck J, Fuchs P, Negroni YL, et al. The Plant cell, 2020. PMID 32796121

  8. Is NADH effective in the treatment of Parkinson's disease?

    ReviewSwerdlow RH Drugs & aging, 1998. PMID 9805207

Search used: ("NADH"[ti] AND (supplementation[tiab] OR oral[tiab])). Run it on PubMed

研究リンク

Also in Vitamins and cofactors

Sold in blends: Lipo-C Fat Blaster, Lipo-C NADH Blend, NADH + Glycine + Histidine + Glutathione + GHK-Cu